NIVEGU.KNOW BEFORE YOU FLY

THE WORLD OF AVIATION.
YOUR JOURNEY, EXPLAINED.

Search Plan my trip
NASDAQ / LIVE COMPANY INTELLIGENCE

Adaptive Biotechnologies Corporation

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERADPT
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / ADPT COVERAGE

What’s moving Adaptive Biotechnologies Corporation now

Current reporting with the operating signal separated from the noise.

01
Adaptive Biotechnologies Corporation (ADPT) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Adaptive Biotechnologies Corporation (ADPT) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

The story matters when it changes Adaptive Biotechnologies Corporation’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
Adaptive Biotechnologies Corporation (ADPT) hit a 52-week high, can the run continue?

Adaptive Biotechnologies Corporation (ADPT) hit a 52-week high, can the run continue?

The story matters when it changes Adaptive Biotechnologies Corporation’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
03
Adaptive Biotechnologies Corporation Prices Upsized $300 Million Convertible Senior Notes Offering

Adaptive Biotechnologies Corporation Prices Upsized $300 Million Convertible Senior Notes Offering

The story matters when it changes Adaptive Biotechnologies Corporation’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
04
Adaptive Biotechnologies Corporation Announces Proposed Convertible Senior Notes Offering

Adaptive Biotechnologies Corporation Announces Proposed Convertible Senior Notes Offering

The story matters when it changes Adaptive Biotechnologies Corporation’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
05
Continued Momentum Lifted Adaptive Biotechnologies Corporation (ADPT) in Q3

Continued Momentum Lifted Adaptive Biotechnologies Corporation (ADPT) in Q3

The story matters when it changes Adaptive Biotechnologies Corporation’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
06
Adaptive Biotechnologies Corporation (ADPT) Hits Fresh High: Is There Still Room to Run?

Adaptive Biotechnologies Corporation (ADPT) Hits Fresh High: Is There Still Room to Run?

The story matters when it changes Adaptive Biotechnologies Corporation’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest ADPT filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-08-04 · Period 2026-06-30SEC ↗10-QQuarterly financial reportFiled 2026-05-05 · Period 2026-03-31SEC ↗10-KAnnual financial reportFiled 2026-02-26 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-07-29 · Period 2026-07-24SEC ↗8-KMaterial company eventFiled 2026-06-22 · Period 2026-06-15SEC ↗8-KMaterial company eventFiled 2026-06-15 · Period 2026-06-15SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-04-24 · Period 2026-06-05SEC ↗4Official SEC filingFiled 2026-09-18 · Period 2026-09-16SEC ↗
EARNINGS / QUARTERLY TRACKER

Adaptive Biotechnologies Corporation, quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.